Omzo vs Mochi Health: Clinician-Guided Care vs Live Video Visits
Quick verdict: Omzo focuses on clinician-guided plans with compounded semaglutide and tirzepatide and medications starting at $179, while Mochi Health emphasizes live video doctor visits and membership-plus-medication pricing from $99/month. This comparison highlights differences in pricing model, visit style, medication sourcing, state access, and regulatory notes.
Explore Omzo clinician-guided plans
Omzo vs Mochi Health: pricing model and starting costs
Price structure is a major practical difference. Omzo lists semaglutide starting at $179 and tirzepatide starting at $279, with medication costs included in fees collected by Omzo. Mochi Health presents a membership-plus-medication model starting from $99/month, with promotional offers such as 50% off the first month and examples like compounded semaglutide starting $99 and compounded tirzepatide starting $199. Mochi also notes a promotional first month rate of $39 for some treatments for new customers while standard monthly membership may be $79 after the promotion depending on state terms.
Visit style and clinical interaction
Omzo connects users with licensed U.S. clinicians through its platform; clinical services are provided by third party networks of U.S.-licensed clinicians who determine eligibility and prescribe at their discretion. Mochi Health distinguishes itself with synchronous live video visits bookable in about 5 minutes, allowing a real-time conversation with a physician who evaluates the case during the visit. Omzo emphasizes clinician-guided plans reviewed by licensed providers; Mochi emphasizes live video appointments and ongoing appointment availability.
Medication sourcing and regulatory notes
Both providers offer compounded medication options and both include the regulatory qualifier that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality. Omzo specifically describes a Compounded Medication Program prepared and shipped by a state-licensed sterile compounding pharmacy and notes that compounded drugs are not FDA-approved. Mochi lists multiple compounded options including weekly injections and an oral semaglutide pill, and likewise states that compounded medications are not FDA-approved.
State access, shipping, and support
Mochi Health claims reliable GLP-1 prescription access in all 50 states and 24/7 support plus ongoing appointments. Omzo notes clinician networks of U.S.-licensed providers and mentions state coverage, pharmacy capacity, and order details can affect availability and rates may vary; Omzo advises confirming eligibility, medication, total cost, renewal terms and state availability before enrollment.
Direct comparison table
| Criteria | Omzo | Mochi Health |
|---|---|---|
| Starting price | Semaglutide starting at $179; tirzepatide starting at $279 | Membership-plus-medication from $99/month; compounded semaglutide examples starting $99 |
| Visit type | Clinician-guided plans reviewed by licensed U.S. providers (async and clinician network) | Live video visits with a doctor bookable in about 5 minutes |
| Medication options | Compounded semaglutide and tirzepatide; providers may prescribe branded meds but Omzo does not sell branded meds | Compounded semaglutide, tirzepatide, oral options and other compounds; membership plus meds |
| State coverage | Provider network with state-dependent availability; confirm before enrollment | Claims prescription access in all 50 states |
| Regulatory note | Compounded medications are not FDA-approved and have not been reviewed by FDA | Compounded medications are not FDA-approved and have not been reviewed by FDA |
What the differences mean for you
If you value a transparent flat starting price that includes medication fees and a clinician-guided program reviewed by licensed U.S. providers, Omzo presents that model with semaglutide starting at $179 and tirzepatide starting at $279. If you prefer a synchronous doctor conversation and broad state access with a membership-plus-medication structure that can have lower promotional entry pricing, Mochi Health emphasizes live video visits in about 5 minutes and membership pricing from $99/month with first month promotions.
See Omzo medication options and start
Safety, limitations, and transparency
Both providers include qualifiers that individual results vary and weight loss outcomes are not guaranteed. Omzo clarifies providers make final prescription determinations and that compounded medications offered are not FDA-approved. Mochi also notes results vary and that pricing is membership plus medication so total monthly cost depends on treatment plan and state terms.
Conclusion: Omzo vs Mochi Health
Omzo vs Mochi Health comes down to clinician-guided, medication-included pricing with compounded options at Omzo versus Mochi’s live video doctor visits and membership-plus-medication pricing from $99/month with promotional first-month offers. Both use compounded medications that are not FDA-approved, so confirm eligibility, state availability, medication type, and total cost with either provider.
Choose Omzo if…
You prefer clinician-guided plans reviewed by licensed U.S. providers with medication fees included and transparent starting prices such as semaglutide starting at $179 and tirzepatide starting at $279, and you will confirm eligibility, renewal terms, and state availability before enrolling.
Choose Mochi Health if…
You want a live video visit with a physician bookable in about 5 minutes, membership-plus-medication pricing that can start as low as $99/month with promotional first month offers, and broad state access with ongoing appointment availability and 24/7 support.
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →